Hosted on MSN22d
EPD Expansion Supports Abbot Stock, Macro Issues PrevailWithin Abbott’s Established Pharmaceuticals Division (EPD) business ... as well as its array of new product launches are expected to help the stock continue its uptrend in the coming days.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results